Major Cancer Biology Students 2010

23rd November 2012: DKFZ-HIGS Graduation Ceremony

Six successful students of the Major Cancer Biology classes of 2009 and 2010 who received their certificates during the DKFZ Graduation Ceremony

It has become a fine tradition once a year at DKFZ to celebrate the PhD and Master students who have successfully completed their thesis work.

On Friday, 23. November 2012 the stage was set in the Lecture Theatre for:
- PhD Poster Presentation Awards
- Major Cancer Biology Masters Program Student Graduation & Fellowship Awards
- PhD Student Council Farewell and Welcome
- Annemarie Poustka Fellowship Awards
- PhD Student Graduation

The event was accompanied by music from a newly founded band of PhD students from HIGS and HBIGS, and followed by a Sekt reception and the legendary Ph.inishe.D party.

October 2010: Welcome to the 23 international students who have joined Major Cancer Biology for the Winter Term 2010/2011:

On October 12, 2010 the students of the year 2010 were welcomed at the DKFZ by Prof. Christof Niehrs, Speaker of the Research Program A "Cell and Tumor Biology", and by the Program Coordinator Dr. Ilse Hofmann.


Theresa AMOAKO (Ghana)


Theresa had joined Major Cancer Biology with a BSc in Biochemistry from Nkrumah University of Science and Technology, Kumasi, Ghana

view Theresa's profile on LinkedIn

Irem BAYINDIR (Turkey)


had joined Major Cancer Biology with a BSc in Molecular Biology and Genetics from the Middle East Technical University, Turkey

view Irem's profile on LinkedIn

David BROCKS (Germany)

David had joined Major Cancer Biology with a BSc in´Medical Biology from the University of Nijmegen, The Netherlands

view David's profile on LinkedIn

Krishna DAS (India)

Krishna had joined Major Cancer Biology with a BTech in Biotechnology from the National Institute of Technology Warangal, India

view Krishna's profile on LinkedIn

Arunraj DHAMODARAN (India)

Arunraj had joined Major Cancer Biology with a BTech in Biotechnology from the Vellore Institute of Technology University, India

view Arunraj's profile on LinkedIn

Nikolaus DIETLEIN (Germany)

Niko had joined Major Cancer Biology with a B.Sc. in Molecular Medicine from the University of Ulm, Germany

Daria EZERINA (Russian Federation)

Daria had joined Major Cancer Biology with a B.Tech. in Chemical Technology and Biotechnology from Lomonosov Moscow State Academy of Fine Chemical Technology, Moscow, Russia

view Daria's profile on LinkedIn

Carlos Alberto FAJARDO (Colombia)

Carlos had joined Major Cancer Biology with a B.Sc. in Biology and a B.Sc. in Microbiology from Universidad de los Andes, Colombia

view Carlos' profile on LinkedIn

Sabrina FEHRENBACH (Germany)

Sabrina had joined Major Cancer Biology with a B.Sc. in Biomedical Sciences from Maastricht University, The Netherlands

view Sabrina's profile on LinkedIn

Julia FRÖSE (Germany)

Julia had joined Major Cancer Biology with a B.Sc. in Biology from Ruhr University Bochum, Germany

view Julia's profile on LinkedIn

Simon HAAS (Germany)

Simon had joined Major Cancer Biology with a B.Sc. in Molecular Cell Biology from University of Heidelberg, Germany

view Simon's profile on LinkedIn

Bogdan JOVANOVIC (Serbia)

Bogdan had joined Major Cancer Biology with a B.Sc. in Biology from University of Belgrade, Serbia

view Bogdan's profile on LinkedIn

Corinna KÖHLER (Germany)

Corinna had joined Major Cancer Biology with a B.Sc. in Molecular Medicine from Ulm University, Germany

view Corinna's profile on LinkedIn

Sabine MARTIN (Germany)

Sabine had joined Major Cancer Biology with a B.Sc. in Biology from University of Heidelberg, Germany

view Sabine's profile on LinkedIn

Moritz MATTHEY (Germany)

Moritz had joined Major Cancer Biology with a B.Sc. in Interdisciplinary Sciences with focus on Biology and Chemistry from the Swiss Federal Institute of Technology ETH Zürich, Switzerland

view Moritz' profile on LinkedIn


Johannes RIDINGER (Germany)

Johannes had joined Major Cancer Biology with a B.Sc. in Molecular Cell Biology from Heidelberg University, Germany

view Johannes' profile on LinkedIn

Oscar Camilo SALGADO BARRERO (Colombia)

College/University Education
08/06–09/10: B.Sc. in Microbiology (Hons.) Universidad de los Andes, Bogotá

Highest Degree
B.Sc. Microbiolgy

Title of Bachelor Thesis
Evaluation of genetic polymorphisms of the 195 bp repeated satellite DNA within Colombian Trypanosoma cruzi DTU I isolates

01/09–05/10: “Tropical Microbiology and Parasitology Research Center” (CIMPAT), Universidad de los Andes (Prof. Felipe Guhl)

Research Interests/Future Plans
Even though my incipient research experience began in the fields of Parasitology and Phylogenetics, I have always realized I want to understand the molecular mechanisms of disease. It would not be easy to find such a disease complex that not only can produce so many different public health problems all around the world, but also represents a huge challenge for almost every discipline inside biological sciences, as cancer. That is why I chose it as my major research topic; and the DKFZ is giving me the opportunity to explore among a vast range of approaches to do so.
With respect to my specific interests, I could say I have special curiosity in the role played by non-coding RNAs in carcinogenesis and metastasis, but first I want to construct a solid background in cancer research to make an informed decision and to choose an area for an eventual Ph.D. degree.

Evelyn SAUTER (Germany)

College/University Education
10/2010-present: pursuing M.Sc. in Cancer Biology, University of Heidelberg and DKFZ
10/2007–09/2010: B.Sc. in Biology, University of Tübingen

Highest Degree
B.Sc. in Biology

Title of Bachelor Thesis
Analyse der Rolle von SRF bei der murinen Gastrulation/ Analysis of the role of SRF during murine gastrulation

Research Interests/Future Plans
My main interests within the large field of cancer research are to understand the alterations and mutations that cause the development of uncontrolled proliferating tumor cells. Therefore I am particularly interested in the alterations in molecular processes of signal transduction pathways and gene regulatory networks, which lead to inadequate regulation of the cell cycle and the avoidance of apoptosis in cancer cells. To develop new approaches in cancer treatment it is essential to understand the complex mechanisms of carcinogenesis. Furthermore, I am interested in the immunological aspects of cancer, particularly how tumor cells are able to evade the immune response. I am looking forward to gain a lot of knowledge and practical skills during the master course in order to pursue a Ph.D. program and finally work as a scientist in cancer research. My goal is to contribute in future development and improvement of therapeutic approaches for cancer treatment. 

Hsin-Chieh TSAY (Taiwan)

University Education
10/2010–present: MSc in Molecular Biosciences with major Cancer Biology, Ruprecht-Karls-University of Heidelberg
09/2005-06/2009: BSc in Medical Laboratory Science and Biotechnology, Taipei Medical University, Taiwan

Highest Degree
Bachelor of Science, Medical Laboratory Science and Biotechnology

Title of Thesis
The expression of neurodegenerative-related biomarkers TGF-Betas, TG2, NF-L, S100Beta, and GFAP in retinas of Ocular Toxocariasis.

Internships/Working Experience
Feb 2007-March 2009: Taipei Medical University (Taipei, Taiwan), the Department of Parasitology of the School of Medicine, Dr. Chia-Kwung Fan’s Laboratory; Volunteer; I conducted the project that was funded by Promoting Academic Excellence of University Students, National Science Council, Taiwan.
Aug 2008-Dec 2008: Cathay General Hospital (Taipei, Taiwan); Medical technician Intern; I worked as a medical technician.
Sept 2009-Apr 2010: National Yang-Ming University (Taipei, Taiwan), the Department and Institute of Microbiology and Immunology, Dr. Shie-Liang Hsieh’s Laboratory; Assistant

Research Interests/Future Plans
Cancer cells are able to escape the immune surveillance and to change the environment that is suitable for them to growth. Those intriguing mechanism really stimulate my eagerness to know how they work. The research topic about immunotherapy of cancer really attracts my attention. Nowadays, the advanced radio and chemotherapy can save many patients’ lives, however, there are still nearly 50% patients die of cancers like leukemia. New therapies need to be developed as soon as possible. Since there are strong and excellent research groups working in German Cancer Research Center, I’ve believed that learning from them can solidify the knowledge about cancer biology, and at the same time, being inspired by their outstanding works. My future plan is to work with other elites in order to develop new therapies to cancer.

Gökçe ÜRENDEN (Turkey)

University Education
10/2010-present: pursuing M.Sc, University of Heidelberg
09/2006-07/2010: B.Sc in Molecular Biology and Genetics, Middle East Technical University, Ankara, TURKEY

Highest Degree
B.Sc in Molecular Biology and Genetics

Title of Bachelor Thesis
Reversal of BCRP-mediated multidrug resistance in breast cancer cell line, MCF-7

06/2008-10/2008: The increase in thermotolerance through the expression of a gene encoding a heatshock protein in Escherichia coli and plasmid isolation, Middle East Technical University, Department of Biological Sciences, Ankara, Turkey (Prof. Dr. Semra Kocabiyik)
06/2009-09/2009: Role of miRNAs in the feedback regulation of EGFR signaling in breast cancer. German Cancer Research Center, Division of Molecular Genome Analysis, Receptor Tyrosine Kinase Signaling Group Heidelberg, Germany (Dr. Özgür Sahin)

Research Interests/Future Plans
After studying molecular biology and genetics, I was quite interested in cancer research. Cancer is a wide-range disease in terms of variations and general therapies mostly are not able to prevent spread of tumors and unfortuntely many people cannot escape from inevitable death. For a successful therapy, every different type of cancer in different people should be investigated at molecular level separately and therapies should be adjusted according to it. My special interest is combination of cancer with pharmacology; so that for each person suffering from cancer, individualized drug treatment could be possible.

Lars VELTEN (Germany)

College/University Education
10/2010–present: pursuing M.Sc., Heidelberg University
10/2007–07/2009: B.Sc. in Molecular Cell Biology, Heidelberg University

Highest Degree
Bachelor of Science (grade 1.0)

Title of Bachelor Thesis
Analysis of the evolutionary potential in Escherichia Coli chemotaxis

02/2009-04/2009: Karsten Weis lab, Department of Molecular & Cell Biology, UC Berkeley; Proteom-wide study of protein turnover as a regulatory mechanism in a SILAC-based approach.
05/2009–11/2009: iGEM team Heidelberg, Bioquant, Heidelberg Universit; Development of a PCR-based, in-silico-guided method for the creation of synthetic promoter elements in cancer cells.
03/2010-06/2010: Victor Sourjik lab, ZMBH, Heidelberg University; Analysis of changes in the bacterial motility gene regulatory network in cells subjected to evolutionary selection pressure for improved chemotaxis.

Research Interests/Future Plans
After having worked on quantitative biology (i.e. systems and synthetic biology) throughout my undergraduate studies, I am now looking forward to getting insights into the application of systems biology in cancer research. High-throughput methods, combined with mathematical modelling, allow for a precise and unprejudiced analysis of a wide range of biological phenomena. My special interests are signal transduction pathways, gene regulatory networks (with an emphasis on the organization of regulatory elements in promoters) and the role of biological noise in establishing stable phenotypes. I am convinced that a thorough understanding of a cell's signal transduction machinery will lead to advances in cancer treatment, esp. with respect to personalized medicine.

Laura WIEHLE (Germany)

University Education

Highest Degree

Title of Bachelor Thesis


Research Interests/Future Plans


Xiaoting WU (Germany)

University Education
10/2010–present: pursuing M.Sc., University of Heidelberg, Germany
09/2009-12/2009: Exchange at Imperial College London, UK
10/2007–07/2010: B.Sc. in Molecular Cellular Biology, University of Heidelberg, Germany

Highest Degree
Bachelor of Science in Molecular Cellular Biology

Title of Bachelor Thesis
The role of cell adhesion molecules in axon navigation

08/2009-09/2009: Phenotype of Panc1/Panc02 cells as influenced by CD95L, German Cancer Research Center, Division of Translational Cancer Research, Dr. A. Martin-Villalba
03/2010-06/2010: The role of cell adhesion molecules in axon navigation, Institute of Zoology, Department of Developmental Neuroscience, Prof. G. E. Pollerberg
07/2010–11/2010: Genetherapy based on synthetic miRNA fine-tuning devices, delivered by modified adeno-associated viruses (in context of iGEM), Bioquant & German Cancer Research Center, Division of Structural and Functional Genomics, Heidelberg, Prof. R. Eils

Research Interests/Future Plans
Since there is often more than one deficiency responsible for a malignancy to arise, I would consider therapies hitting multiple targets as very promising. Viro- and immunotherapy are smart ways to confront the challenge. Those therapeutic approaches exploit general properties of cancer cells for eliminating malignant cells. Apart from this I am very excited about the “engineering” aspect of virotherapy. Modern concepts in virotherapy do not rely on wild type viruses, but rather on highly engineered strains. Biology has reached a stage where the de novo construction of small biological systems (such as viruses) has become possible.
A further interest of mine is systems biology of cancer, where the information of basic research comes together to form a whole picture and network. So I am enthused to gain a deeper insight into these fields.

to top
powered by webEdition CMS